Skip to main content
logo
Viva Biotech Holdings (HKG:1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.590
+0.010 (0.63%)
Aug 21, 2026, 4:08 PM HKT

Viva Biotech Holdings Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
219.76167.29-116.11-528.48287.55
Depreciation & Amortization
211.05213.86211.22185.45153.15
Loss (Gain) From Sale of Assets
4.671.91-0.281.94.84
Asset Writedown & Restructuring Costs
15.9938.6113.82--
Loss (Gain) From Sale of Investments
-148.61-78.1119.81373.59-53.75
Loss (Gain) on Equity Investments
4.50.1---
Stock-Based Compensation
0.584.1919.0124.8220.58
Other Operating Activities
43.8559.08204.54346.67-73.03
Change in Accounts Receivable
36.22-18.6830.44-22.31-98.51
Change in Inventory
-64.88-17.4857.04-96.44-69.07
Change in Accounts Payable
-97.1163.6-80.3745.08-16.44
Change in Unearned Revenue
-12.530.39-19.72-18.7-5.74
Change in Other Net Operating Assets
18.73-60.7744.0374.47-71.76
Operating Cash Flow
232.23373.99383.41386.0577.83
Operating Cash Flow Growth
-37.91%-2.46%-0.69%396.02%80.24%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-121.16-190.67-187.68-249.33-565.18
Sale of Property, Plant & Equipment
1.360.550.650.661.58
Cash Acquisitions
----81.2-210.87
Divestitures
-1532.34--
Sale (Purchase) of Intangibles
-1.39-1-0.16-0.21-1.15
Investment in Securities
58.29137.950.11-48.03-159.05
Other Investing Activities
-16.69224.12543.915.3165.84
Investing Cash Flow
-79.59185.9439.17-372.8-868.84

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
905.91,1202,045673.04565.03
Total Debt Issued
905.91,1202,045673.04565.03
Long-Term Debt Repaid
-865.06-1,740-2,875-745.6-989.64
Total Debt Repaid
-865.06-1,740-2,875-745.6-989.64
Net Debt Issued (Repaid)
40.84-620.51-829.54-72.56-424.61
Issuance of Common Stock
1.74---18.23
Repurchase of Common Stock
-4.99-23.02-10.27--146.19
Common Dividends Paid
-----16.27
Dividends Paid
-----16.27
Other Financing Activities
-37.38-14.23410.32-70.64-84.31
Financing Cash Flow
0.2-657.76-429.5-143.2-653.16

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-5.783.26-35.327.57-63.34
Net Cash Flow
147.06-94.61357.75-122.38-1,508

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
111.07183.32195.73136.72-487.35
Free Cash Flow Growth
-39.41%-6.34%43.16%--
Free Cash Flow Margin
6.42%9.23%9.08%5.75%-23.16%
Free Cash Flow Per Share
0.050.060.100.07-0.25
Levered Free Cash Flow
-175.2310.11143.452.66-429.06
Unlevered Free Cash Flow
-151.75343.8253.82118.08-314.62

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
37.3853.7670.6972.8671.28
Cash Income Tax Paid
67.8879.1380.3380.5145.15
Change in Working Capital
-119.57-32.9431.42-17.91-261.52